Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Hong Kong's CKI makes £7bn bid for majority stake in Thames Water - report

(Sharecast News) - Hong Kong's CK Infrastructure has reportedly made a preliminary £7bn bid to take a majority stake in Thames Water, while indicating that it would require the company's bondholders to take significant haircuts. The Financial Times on Friday cited two people familiar with the matter as saying that CKI, which is part of CK Hutchison group, submitted the non-binding offer earlier this month.

While CKI indicated it would be willing to inject £7bn of equity to fix the utility's broken balance sheet, its offer is contingent on bondholders in Thames Water's near-£20bn debt pile agreeing to take significant writedowns, sources told the FT.

It was understood that CK Hutchison's majority stake in Northumbrian Water could also prove a sticking point. The group is not keen to dispose of its 75% stake in the other regional water monopoly, the sources said, which may cause issues with competition regulators.

Thames Water received several non-binding bids earlier this month, including a rival £4bn bid from US private equity firm KKR.

The water utility is looking to raise billions of pounds in equity while negotiating a debt restructuring with its lenders in a bid to avoid insolvency.

Thames Water declined to comment to the FT, while a representative for CKI did not immediately respond to a request for comment.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.